Cimzia (certolizumab pegol) / UCB, Ferring, Astellas  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cimzia (certolizumab pegol) / Astellas, UCB
TICIMEL, NCT03293784: TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma

Completed
1
33
Europe
Nivolumab+Ipilimumab in combination with Anti TNF-α Certolizumab, Nivolumab+Ipilimumab in combination with Anti TNF-α Infliximab
Institut Claudius Regaud
Melanoma
12/19
08/23
CHERISH, NCT04163016: A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)

Completed
1
22
Europe, US
Pharmacokinetics of certolizumab pegol, PK
UCB Biopharma SRL
Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease, Axial Spondyloarthritis, Plaque Psoriasis
05/23
05/23

Download Options